LHC Group

LHC — Q3 2020 Earnings Presentation

33 slides from LHC's earnings presentation, Nov 5, 2020

  1. Slide 1: Supplemental Financial Information Third Quarter Ended September 30, 2020

    Supplemental Financial Information Third Quarter Ended September 30, 2020 November 4, 2020 Exhibit 99.2

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements This presentation contains “forward-looking statements” (as defined in the Securities Litigation Reform Act of 1995) regarding, among other things, future events or the future financial performance of the Company. Words such as “anticipate,” “expect,” “project,” “intend,”

  3. Slide 3: Table of Contents

    Table of Contents Company overview Commentary on Q3 2020 COVID-19 update Consolidated results Adjustments to net income Medicare Shared Savings Program Q3 impact Segment results Guidance Acquisitions and joint ventures Quality data Debt and liquidity metrics Focus for remainder of 2020 31-32 Non-GAA

  4. Slide 4: LHC Group Overview

    Home Health Hospice HCBS Home Health & Hospice Home Health & HCBS Home Health, Hospice, & HCBS LHC Group Overview 549 home health locations 60% Of U.S. population aged 65+ included in service area 111 hospice locations 122 home & community based services locations 12 Long term acute care hospitals l

  5. Slide 5: Commentary on Q3 2020

    After experiencing maximum year-to-date headwinds from COVID-19 in mid-April, organic growth, average daily census and admissions in home health and hospice steadily increased through Q3. Home Health average daily census is currently 12.4% higher than COVID induced low point and 7.1% higher than pre

  6. Slide 6: COVID-19 Update

    Multi-disciplinary internal COVID-19 task force continues to meet weekly and send company wide COVID-19 related communications daily. Every employee is screened daily based on CDC guidelines, and every patient (regardless of condition) is seen by a clinician with at least face mask and gloves while

  7. Slide 7: COVID-19 Update: Home Health and Hospice Growth Trends

    COVID-19 Update: Home Health and Hospice Growth Trends Same Store Organic Admission Growth by 2020 Period over Same Period in 2019 Jan 2020 Feb 2020 Mar 2020 Q1 2020 Home Health 9.8% 13.4% -1.6% 7.1% Hospice 1.5% 2.5% -3.1% 0.2% Apr 2020 May 2020 Jun 2020 Q2 2020 Home Health -14.3% -6.7% 7.0% -4.7%

  8. Slide 8: COVID-19 Update: New Physician Home Health Referral Sources

    COVID-19 Update: New Physician Home Health Referral Sources 2019 2020 Growth January 1,392 1,474 5.9% February 1,161 1,282 10.4% March 1,241 1,159 -6.6% April 1,184 1,205 1.8% May 1,169 1,294 10.7% June 1,091 1,497 37.2% July 1,078 1,512 40.3% August 1,150 1,553 35.0% September 1,003 1,517 51.2% Sep

  9. Slide 9: COVID-19 Update: Home Health Same Store Organic Admission Growth by State

    State % of total HH volume Q2 2020 Q3 2020 Florida 9.0% 5.4% 14.0% Tennessee 8.8% -2.6% 2.3% Kentucky 7.7% -5.0% -1.8% Alabama 7.5% -7.3% 0.5% Mississippi 6.6% -3.2% 0.8% Louisiana 6.3% 6.7% 12.1% Arkansas 6.3% -14.0% 0.8% Pennsylvania 5.6% -16.2% -5.8% Texas 4.8% 7.2% 22.5% West Virginia 4.1% -5.5%

  10. Slide 10: COVID-19 Update: Pre COVID-19 Trends Compared with Current Trends

    COVID-19 Update: Pre COVID-19 Trends Compared with Current Trends continued Monthly Home Health, Hospice and HCBS Trends Week Ending January 2020 February 2020 March 2020 April 2020 May 2020 June 2020 July 2020 August 2020 September 2020 October 2020 Home Health: Average census 75,027 77,391 78,515

  11. Slide 11: COVID-19 Update: Financial Impact of CARES Act Policies

    COVID-19 Update: Financial Impact of CARES Act Policies Near-term financial benefits are substantial Estimated 2020 financial impact Provider Relief Fund As of September 30, 2020, we have received funds totaling $93.3 million related to the Provider Relief Fund as provided for by the CARES Act. Duri

  12. Slide 12: COVID-19 Update: CARES Act Policy Implications

    COVID-19 Update: CARES Act Policy Implications Potential benefits that could lead to new homecare policies post-COVID-19 Policy Benefit Nurse Practioners and Physician Assistants are permanently authorized to order and certify home health services. Nurse Practitioners and Physician Assistants can or

  13. Slide 13: 2020 Adjusted Consolidated Results

    2020 Adjusted Consolidated Results Three months ended September 30 Nine months ended September 30 Consolidated Total Adjustments Adjusted Consolidated Consolidated Total Adjustments Adjusted Consolidated Net service revenue $530,684 $0 $530,684 $1,530,875 $0 $1,530,875 Cost of service revenue 305,24

  14. Slide 14: Adjusted Consolidated Results – 2020 vs 2019

    Adjusted Consolidated Results – 2020 vs 2019 Three months ended September 30 Nine months ended September 30 2020 Adjusted Consolidated % of rev 2019 Adjusted Consolidated % of rev 2020 Adjusted Consolidated % of rev 2019 Adjusted Consolidated % of rev Net service revenue $530,684 $528,499 $1,530,875

  15. Slide 15: Adjustments to Net Income

    Adjustments to Net Income PRE-TAX ADJUSTMENTS Q3 2020 Q3 2019 YTD 2020 YTD 2019 Acquisition and de novo expenses (1) $2,492 $11,731 $4,556 $28,305 Closures/relocations/consolidations (2) $0 $1,302 $1,174 $6,536 COVID-19 PPE, supplies and other expenses (3) $10,474 $0 $40,609 $0 Provider Relief Fund

  16. Slide 16: Adjustments to Net Income per Diluted Share

    Adjustments to Net Income per Diluted Share ADJUSTMENTS NET OF TAX Q3 2020 Q3 2019 YTD 2020 YTD 2019 Acquisition and de novo expenses (1) $0.05 $0.27 $0.11 $0.66 Closures/relocations/consolidations (2) $0 $0.03 $0.03 $0.15 COVID-19 impact: PPE, supplies and other expenses (3) $0.25 $0 $0.95 $0 CARES

  17. Slide 17: Medicare Shared Savings Program Q3 Impact

    Medicare Shared Savings Program Q3 Impact Adjusted Q3 (Includes $9.6 million in MSSP*) Q3 with budgeted MSSP (Includes $5.0 million in MSSP*) Normalized Q3 (Excluding MSSP*) Revenue $530.7 million $526.1 million $521.1 million EPS $1.63 $1.52 $1.40 EBITDA $74.5 million $70.0 million $65.0 million Th

  18. Slide 18: Three Months Ended Sep. 30, 2020 Adjusted Segment Results

    Three Months Ended Sep. 30, 2020 Adjusted Segment Results Home health services Adjustments Adjusted Home health services Hospice services Adjustments Adjusted Hospice services HCBS services Adjustments Adjusted HCBS services Net service revenue $373,450 $373,450 $59,801 $59,801 $48,387 $48,387 Cost

  19. Slide 19: Nine Months Ended Sep. 30, 2020 Adjusted Segment Results

    Nine Months Ended Sep. 30, 2020 Adjusted Segment Results Home health services Adjustments Adjusted Home health services Hospice services Adjustments Adjusted Hospice services HCBS services Adjustments Adjusted HCBS services Net service revenue $1,081,143 $0 $1,081,143 $181,387 $0 $181,387 $144,526 $

  20. Slide 20: Home Health Services Adjusted Results – 2020 vs 2019

    Three months ended September 30, Nine months ended September 30, 2020 Adjusted Home health services % of rev 2019 Adjusted Home health services % of rev 2020 Adjusted Home health services % of rev 2019 Adjusted Home health services % of rev Net service revenue $373,450 $375,599 $1,081,143 $1,113,887

  21. Slide 21: Home Health Revenue Factors

    % of P2s out of total 30-day periods Institutional admit % LUPA % 60-day case mix March 2020 42.8% 67.3% 8.8% 1.0260 April 2020 43.1% 58.1% 11.4% 0.9926 May 2020 44.0% 57.8% 8.8% 0.9904 June 2020 44.2% 59.4% 8.2% 0.9957 July 2020 43.4% 60.9% 8.6% 1.0065 August 2020 43.7% 59.8% 8.6% 1.0076 September

  22. Slide 22: Hospice Services Adjusted Results – 2020 vs 2019

    Three months ended September 30, Nine months ended September 30, 2020 Adjusted Hospice services % of rev 2019 Adjusted Hospice services % of rev 2020 Adjusted Hospice services % of rev 2019 Adjusted Hospice services % of rev Net service revenue $59,801 $62,028 $181,387 $168,821 Cost of service reven

  23. Slide 23: HCBS Services Adjusted Results – 2020 vs 2019

    Three months ended September 30, Nine months ended September 30, 2020 Adjusted HCBS services % of rev 2019 Adjusted HCBS services % of rev 2020 Adjusted HCBS services % of rev 2019 Adjusted HCBS services % of rev Net service revenue $48,387 $53,411 $144,526 $157,610 Cost of service revenue 36,647 75

  24. Slide 24: Facility-Based Services Segment Adjusted Results – 2020 vs 2019

    Facility-Based Services Segment Adjusted Segment Results – 2020 vs 2019 Three months ended September 30, Nine months ended September 30, 2020 Adjusted Facility-based services % of rev 2019 Adjusted Facility-based services % of rev 2020 Adjusted Facility-based services % of rev 2019 Adjusted Facility

  25. Slide 25: Healthcare Innovations Segment Adjusted Results – 2020 vs 2019

    Healthcare Innovations Segment Adjusted Segment Results – 2020 vs 2019 Three months ended September 30, Nine months ended September 30, 2020 Adjusted HCI services % of rev 2019 Adjusted HCI services % of rev 2020 Adjusted HCI services % of rev 2019 Adjusted HCI services % of rev Net service revenue

  26. Slide 26: Increased FY 2020 Guidance

    Increased FY 2020 Guidance Original FY 2020 Guidance issued on February 27, 2020 Reinstated FY 2020 Guidance issued on August 5, 2020 Updated FY 2020 Guidance Revenue $2.13 billion to $2.18 billion $2.0 billion to $2.05 billion $2.06 billion to $2.07 billion EPS $4.60 to $4.80 $4.60 to $4.80 $4.90 t

  27. Slide 27: Acquisition and Joint Ventures Accelerate Again in Second Half of 2020

    Acquisition and Joint Ventures Accelerate Again in Second Half of 2020 Acquisition/Joint Venture Partner State Date Closed Locations Annual Revenue DFW Home Health Texas Health Resources/Methodist Health System Texas 1/1/2020 1 $2,400,000 LifePoint Health LifePoint Health Arkansas 1/1/2020 2 $5,400,

  28. Slide 28: Industry-Leading Quality and Patient Satisfaction

    Industry-Leading Quality and Patient Satisfaction 85% of LHC Group same-store providers have CMS 4 stars or greater for quality Quality October 2020 LHC Group excluding 2019 acquisitions 4.27 LHC Group with 2019 acquisitions 4.23 National average 3.25 Patient Satisfaction October 2020 LHC Group excl

  29. Slide 29: Debt and Liquidity Metrics

    Debt and Liquidity Metrics Outstanding Debt (amounts in thousands) As of Sep. 30, 2020 Total Debt – Balance Sheet $20,000 Less: Cash $253,764 Net Debt NA Net debt to estimated TTM adjusted EBITDA ratio NA Credit Facility (amounts in thousands) As of Sep. 30, 2020 Revolver Size $500,000 Less: Outstan

  30. Slide 30: Focus for Remainder of 2020

    Focus for Remainder of 2020 Continue the successful execution of our PDGM clinical pathway and efficiency plan. Maintain disciplined capital allocation with new joint ventures and other M&A activity. Accelerate plans for unlocking untapped potential of co-location strategy. Maximize value of Healthc

  31. Slide 31: Non-GAAP Reconciliations

    Non-GAAP Reconciliations (Amounts in thousands, unaudited) RECONCILIATION OF ADJUSTED NET INCOME ATTRIBUTABLE TO LHC GROUP Three Months Ended Sep. 30, Three Months Ended Sep. 30, Nine Months Ended Sep. 30, Nine Months Ended Sep. 30, 2020 2019 2020 2019 Net income attributable to LHC Group, Inc.’s co

  32. Slide 32: Footnotes

    Footnotes: Expenses and other costs associated with recently announced or completed acquisitions and de novos ($2.5 million and $4.6 million pre-tax in the third quarter and first nine months of 2020, respectively). Loss on the sale of an asset and other expenses associated with a closure on consoli

  33. Slide 33: LHC Group – It's all about helping people

    a LHC Gir © wy IP It’s all about helping people.

LHC Group — Q3 2020 Earnings Presentation on 6ix